You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

DCI Center for Prostate & Urologic Cancers Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

With Robust Molecular Tumor Registry "MrT," The Stars Align

Some of the newest and most exciting cancer drugs target tumors that have a specific genetic mutation or characteristic. These targeted therapies block the growth and spread of cancer by interfering with specific molecular targets on those tumors that are involved in the growth, progression and...

New Robotic Surgical Innovation Helps Nurse Recover

Duke University Hospital recently performed a surgery using the new da Vinci SP® Single Port Surgical System by Intuitive Surgical, becoming one of only 15 medical sites in the country with the single port robot. Duke is also the first hospital in North Carolina to use this new innovation, which is...

DOD Awards $1.6 Million To Study Health Disparity in Prostate Cancer

A group of researchers led by Daniel George, MD, professor of medicine and surgery at Duke Cancer Institute, have recently been awarded $1,609,691 from the Department of Defense Prostate Cancer Research Program ( PCRP ) to study health disparity in metastatic prostate cancer. George’s project is...

Duke AUA 2019 Recap

Duke 2019 AUA Recap Duke Urology and the DCI Center for Prostate & Urologic Cancers recently presented at the 2019 American Urological Association (AUA) Annual Meeting in Chicago, Illinois. Now in its 114thyear, the AUA Annual Meeting is the largest gathering of urologists in the world. The...

Doctors Take A Plunge For Cancer Research

Ready for a good soaking, oncologists from the DCI Center for Prostate and Urologic Cancers and colleagues from around Duke Cancer Institute participated in taking a chilly plunge on May 16, 2019, to raise funds and awareness for breakthrough prostate urologic cancer research. “We couldn’t have...

Study Finds How Prostate Cancer Cells Mimic Bone When They Metastasize

Prostate cancer often becomes lethal as it spreads to the bones, and the process behind this deadly feature could potentially be turned against it as a target for bone-targeting radiation and potential new therapies. In a study published online Tuesday in the journal PLOS ONE , Duke Cancer...

The OncoPig Cancer Model

Join us for a presentation by Lawrence Schook, MD, Edward William and Jane Marr Gutsgell Professor of Animal Sciences and Radiology at the University of Illinois, on "The Oncopig Cancer Model (OCM): A Platform for Transitional, Translational and Transformative Advances in Cancer Research." Location...

Duke Scientists Receive NCI R01 Grant

The National Cancer Institute (NCI) awarded $2.1 Million to Duke Cancer Institute (DCI) researchers to study plasmonic nanoparticle-mediated immunotherapy to treat metastatic bladder cancer. Co-principal investigators, Brant Inman, MD, MS, and Tuan Vo-Dinh, PhD, developed a novel two-pronged...

Team Easy Riders: Committed To Changing The Course Of Cancer

According to the American Cancer Society, one in two men and one in three women in the United States will be affected by cancer in their lifetime. It is estimated that in 2018 there will be 1,762,450 new cancer cases diagnosed — 58,690 of those in North Carolina. In keeping with its mission to...

DCI Center for Prostate & Urologic Cancers Present at EAU

Physician-scientists from DCI Center for Prostate & Urologic Cancers recently presented data at the 2019 European Association of Urology (EAU) Congress held in Barcelona, Spain, from March 15 -19. Held annually, over 10,000 colleagues throughout the world gather for the scientific retreat to...

Controversies In Prostate Cancer Treatment & Screening (3.27.19)

Social scientist Jenny Donovan, PhD, FMedSci, a visiting scholar at the Durham VA Health System's Cooperative Studies Program Epidemiology Center (CSPEC) and Duke University, will deliver a talk on "Randomized trials for controversies in prostate cancer treatment and screening: recruitment and...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Pages